(Q40526582)

21 September 2017

title

Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus (English)

1 reference

21 September 2017

1 reference

Katsunori Shinozaki

1

1 reference

21 September 2017

Oliver Ebert

2

1 reference

21 September 2017

Chryssanthi Kournioti

3

1 reference

21 September 2017

Yun-Sheng Tai

4

1 reference

21 September 2017

Savio L C Woo

5

1 reference

21 September 2017

publication date

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

9

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

368-376

1 reference

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Estimating the world cancer burden: Globocan 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Rising incidence of hepatocellular carcinoma in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

7 January 2021

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Epidemiology of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Factors affecting the prognosis of primary liver carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Liver transplantation for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Reovirus therapy of tumors with activated Ras pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Systemic therapy of myeloma xenografts by an attenuated measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Gene therapy for malignant liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Telomerase-dependent oncolytic adenovirus for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Control of early viral and bacterial distribution and disease by natural antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Immune responses in interleukin-2-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Recombinant vesicular stomatitis viruses from DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

10.1016/J.YMTHE.2003.12.004

7 January 2021

Identifiers

DOI

1 reference

release_75zc35d36fhnfos3ryrk44lufe

21 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/75zc35d36fhnfos3ryrk44lufe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference